GLP-1 plus peptide stacks: The muscle loss trap doctors need to flag
Industry Buzz
The problem we see with the GLP that no amount of muscle-stimulating peptides will fix is [that] if a patient is undereating due to GLP-1 effects, the body may still prioritize survival over muscle preservation, even with elevated growth hormone signals.
—Betsy Greenleaf, DO
“Would adding CJC 1295 and Ipamorelin prevent severe muscle wasting and ensure the body only cuts mostly fat?” a Reddit user asked in r/Peptides while discussing semaglutide.
Another wrote, “I’ve been on liraglutide (Saxenda) with a blend of Ipamorelin, Mod GRF and Frag and the weight torched off of me.” A third reported a DEXA scan after major weight loss: “I’ve lost 75lbs and 26lbs of it was muscle.”
Why are patients pairing GLP-1 with peptides?
Patients are taking GLP-1 receptor agonists for fat loss, then adding growth hormone secretagogues, “repair” peptides, or recovery stacks to protect muscle, preserve skin tightness, train harder, or avoid the “Ozempic body.”
Betsy Greenleaf, MD, a board-certified urogynecologist, explains, “One of the challenges we have with the GLP peptides is that the weight loss that some people experience from improved sense of fullness, decreased taste satisfaction, and decreased food-searching activity can also lead to a loss of muscle mass in addition to fat.”
A 2025 review in the International Journal of Obesity stated that an estimated 30% to 40% of GLP-1 RA-associated weight loss may derive from fat-free mass, which is of particular concern for older adults and patients with sarcopenic obesity. []
The same paper emphasized high-quality protein intake and resistance training as core strategies for preserving muscle.
Dr. Greenleaf says that nearly 40% of the weight loss from GLP-1s is due to muscle loss. “As we age, we are already battling losing 8% to 10% muscle mass per decade. We need muscle for metabolic activity because muscle is thermogenic [and] burns more calories to maintain; thus, if you lose weight and lose muscle, you may risk affecting your metabolism to the point where the weight is gained back—and then some—easily after stopping GLP medications. … So the idea of stacking other peptides, especially those to prevent muscle mass, is a common practice that I am seeing more and more.”
While using peptides under clinical supervision can be useful, according to Dr. Greenleaf, “The problem we see with the GLP that no amount of muscle-stimulating peptides will fix is [that] if a patient is undereating due to GLP-1 effects, the body may still prioritize survival over muscle preservation, even with elevated growth hormone signals. If the body is not getting the basic building blocks for muscle, which are nutrients from whole foods and proteins, the stacking is not going to work.”
Related: Your patient lost weight on a GLP-1. Now they’re back with all new concerns. Here’s how to respondPatient evaluation
A 2025 joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society also emphasizes nutrition assessment, adequate protein, micronutrient monitoring, and resistance training during GLP-1 therapy. []
Dr. Greenleaf’s counseling message is direct: “You can't get Arnold Schwarzenegger’s physique by just sitting on the couch and pounding peptides.”
Peptides are tools, she says, not substitutes for protein, nutrients, hormonal balance, recovery, and strength training.
For patients already stacking, document each compound, source, dose, route, schedule, and start date, and then monitor glucose, HbA1c, lipids, liver enzymes, renal function, blood pressure, IGF-1 (when relevant), body composition, and injection sites.